Senior Bill of Rights Act of 2003
Latest action · May 21, 2003 Referred to the Subcommittee on Health.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedApr 10, 2003
- Passed HouseNot reached
- Passed SenateNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Establishes a Medicare Prescription Medicine Advisory Committee.
Amends SSA title XVIII part C (Medicare+Choice) to require Medicare+Choice organizations to make actuarially equivalent outpatient prescription medicines available under their plans. Requires Medigap policies also to cover such medicines. Provides for transitional assistance to low-income beneficiaries.
Prescription Drug Fairness for Seniors Act of 2003 - Requires each participating manufacturer to make covered outpatient drugs available at a price no greater than the manufacturer's average foreign price. Declares the sense of Congress that the cost disparity between identical prescription drugs sold in the United States, Canada, and Mexico should be reduced or eliminated.
Amends the Internal Revenue Code to disallow any deduction for any amount paid or incurred for a direct-to-consumer advertisement of a prescription drug.
Greater Access to Affordable Pharmaceuticals Act of 2003 - Amends the Federal Food, Drug, and Cosmetic Act (FFDCA) with respect to: (1) abbreviated new generic drug applications, including forfeit to the next applicant by previous applicants who fail to market a drug within 90 days of approval or meet other specified requirements; (2) specified bioequivalence tests other than those for absorption rate and extent assessment; (3) requirements for citizen petitions regarding new drug applications; (4) actions for patent infringement; and (5) requirements for new drug applications, including mandatory patent information.
Preserving Access to Safe Affordable Canadian Medicines Act of 2003 - Amends FFDCA to prohibit prescription medication manufacturers from taking actions to discriminate against, or cause other persons to discriminate against, U.S. consumers regarding the purchase of prescription medications from Canadian pharmacies.
Prohibits the Commissioner of Food and Drugs from approving any new drug application that does not, before completion of the approval process, provide the Secretary a written statement specifying the total cost of research and development with respect to such drug.
Amends the Federal Election Campaign Act of 1971 to prohibit the chief executive officer of a pharmaceutical company from contributing to a political party or candidate.
Rescinds the February 2002 veterans medication copayment increase, and reinstates the $2 copayment.
Declares that all Social Security and Medicare funds shall be walled off into a lock box that may not be raided for new programs or tax cuts for the rich.
Cosponsors 10
Members who signed on, in the order they did. Signatures ran from Apr 10, 2003 to Jun 3, 2003; 6 are original cosponsors, there from the day it was introduced.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| I-VT | Bernard Sanders | Original | Apr 10, 2003 |
| D-MI | Dale E. Kildee | Original | Apr 10, 2003 |
| D-OH | Marcy Kaptur | Original | Apr 10, 2003 |
| D-TX | Martin Frost | Original | Apr 10, 2003 |
| D-NY | Michael R. McNulty | Original | Apr 10, 2003 |
| D-ME | Thomas H. Allen | Original | Apr 10, 2003 |
| D-NY | Charles B. Rangel | Apr 29, 2003 | |
| D-NY | Major R. Owens | Apr 29, 2003 | |
| D-NY | Steve Israel | May 1, 2003 | |
| D-AZ | Raúl M. Grijalva | Jun 3, 2003 |
Committees 4
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| House | Energy and Commerce Committee | Referred Apr 10, 2003 |
| Health Subcommittee | Referred Apr 24, 2003 | |
| House | Ways and Means Committee | Referred Apr 10, 2003 |
| Health Subcommittee | Referred Apr 23, 2003 | |
| House | Veterans' Affairs Committee | Referred Apr 10, 2003 |
| Health Subcommittee | Referred May 21, 2003 | |
| House | Committee on House Administration | Referred Apr 10, 2003 |
Actions 5
Everything that happened, newest first.
- May 21, 2003Referred to the Subcommittee on Health.
- Apr 24, 2003Referred to the Subcommittee on Health.
- Apr 23, 2003Referred to the Subcommittee on Health.
- Apr 10, 2003Introduced in House
- Apr 10, 2003Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, Veterans' Affairs, and House Administration, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Titles 5
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- To amend XVIII and XIX of the Social Security Act to provide for a voluntary Medicare prescription medicine benefit, to provide greater access to affordable pharmaceuticals, to provide for substantial reductions in the cost of prescription drugs made available to Medicare beneficiaries, to amend the Internal Revenue Code of 1986 to disallow deductions for direct-to-consumer advertisement of prescription drugs, to amend the Federal Food, Drug, and Cosmetic Act to provide greater access to affordable pharmeceuticals and preserving access to safe affordable Canadian medicines, to amend the Federal Election Campaign Act of 1971 to prohibit campaign contributions by chief executive officers of pharmeceutical companies, and for other purposes.
- Short Titles as Introduced
- Senior Bill of Rights Act of 2003
- Short Titles as Introduced for portions of this bill
- Preserving Access to Safe Affordable Canadian Medicines Act of 2003
- Greater Access to Affordable Pharmaceuticals Act of 2003
- Prescription Drug Fairness for Seniors Act of 2003
Subjects
Assigned by the Library of Congress. Policy area: Health.
- Access to health care
- Administrative procedure
- Administrative remedies
- Antibiotics
- Armed Forces and National Security
- Auditing
- Business records
- Campaign funds
- Canada
- Chief executive officers
- Civil actions and liability
- Civil Rights and Liberties, Minority Issues
- Coinsurance
- Commerce
- Competition
- Competitive bidding
- Congress
- Congressional elections
- Congressional reporting requirements
- Consumer complaints
- Consumer discounts
- Cost control
- Costs
- Department of Health and Human Services
- Disabled
- Drug advertising
- Drug approvals
- Drug industry
- Drug interactions
- Drugs
- Economics and Public Finance
- Employee health benefits
- Federal advisory bodies
- Federal aid to research
- Finance and Financial Sector
- Fines (Penalties)
- Foreign Trade and International Finance
- Generic drugs
- Government contractors
- Government Operations and Politics
- Government paperwork
- Government publicity
- Government trust funds
- Governmental investigations
- Health
- Health care fraud
- Health education
- Health insurance
- Health insurance continuation
- Health maintenance organizations
- Imports
- Income tax
- Indexing (Economic policy)
- Injunctions
- Insulin
- Insurance premiums
- Intellectual property
- Labor and Employment
- Latin America
- Law
- Managed care
- Medicaid
- Medical economics
- Medical records
- Medicare
- Medigap
- Mexico
- Old age, survivors and disability insurance
- Patent infringement
- Patents
- Patient satisfaction
- Pharmaceutical research
- Pharmacies
- Prescription pricing
- Presidential elections
- Price discrimination
- Quality of care
- Rebates
- Research and development
- Research grants
- Restrictive trade practices
- Retiree health benefits
- Right of petition
- Right of privacy
- Science, Technology, Communications
- Social security finance
- Social Welfare
- Standards
- Tax deductions
- Tax rates
- Taxation
- Telephone
- Terminal care
- Veterans' medical care
Text 1
Each version as it was printed, newest first.
- Apr 10, 2003Introduced in House
Support LegiList
This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.